Related Experiment Video
Updated: May 21, 2026
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Ruling out coronary heart disease in primary care: external validation of a clinical prediction rule
Jörg Haasenritter1, Stefan Bösner, Paul Vaucher
1Department of General Practice/Family Medicine, Phillips University of Marburg, Marburg, Germany. haasenri@staff.uni-marburg.de
Insights
The Marburg Heart Score (MHS) accurately helps general practitioners (GPs) rule out coronary heart disease (CHD) in patients with chest pain. Its high negative predictive value supports its use in clinical practice.
Area of Science:
- Cardiology
- General Practice
- Diagnostic Accuracy Studies
Background:
- The Marburg Heart Score (MHS) is designed to aid general practitioners (GPs) in assessing patients presenting with chest pain.
- It aims to safely exclude coronary heart disease (CHD) and guide subsequent management decisions.
Purpose of the Study:
- To evaluate the diagnostic accuracy of the MHS in an independent patient cohort.
- To assess the generalizability of the MHS to new patient populations.
Main Methods:
- A cross-sectional diagnostic study was conducted in general practices in Hesse, Germany.
- 844 adult patients presenting with chest pain were recruited, and their data, including MHS items, were collected.
- A 6-month follow-up with expert panel review established the reference standard for CHD diagnosis.
Main Results:
- The Marburg Heart Score demonstrated a strong diagnostic performance with an area under the receiver operating characteristic curve (AUC) of 0.84.
- At a cut-off value of 3, the MHS achieved a sensitivity of 89.1% and a high negative predictive value of 97.9% for detecting CHD.
- Specificity was 63.5%, with a positive predictive value of 23.3%.
Conclusions:
- The Marburg Heart Score exhibits good diagnostic accuracy and generalizability for assessing chest pain patients in primary care.
- Its ease of application supports its recommended use in routine clinical practice for ruling out CHD.
Background:
The Marburg Heart Score (MHS) aims to assist GPs in safely ruling out coronary heart disease (CHD) in patients presenting with chest pain, and to guide management decisions.
Aim:
To investigate the diagnostic accuracy of the MHS in an independent sample and to evaluate the generalisability to new patients.
Design And Setting:
Cross-sectional diagnostic study with delayed-type reference standard in general practice in Hesse, Germany.
Method:
Fifty-six German GPs recruited 844 males and females aged ≥ 35 years, presenting between July 2009 and February 2010 with chest pain. Baseline data included the items of the MHS. Data on the subsequent course of chest pain, investigations, hospitalisations, and medication were collected over 6 months and were reviewed by an independent expert panel. CHD was the reference condition. Measures of diagnostic accuracy included the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, likelihood ratios, and predictive values.
Results:
The AUC was 0.84 (95% confidence interval [CI] = 0.80 to 0.88). For a cut-off value of 3, the MHS showed a sensitivity of 89.1% (95% CI = 81.1% to 94.0%), a specificity of 63.5% (95% CI = 60.0% to 66.9%), a positive predictive value of 23.3% (95% CI = 19.2% to 28.0%), and a negative predictive value of 97.9% (95% CI = 96.2% to 98.9%).
Conclusion:
Considering the diagnostic accuracy of the MHS, its generalisability, and ease of application, its use in clinical practice is recommended.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:27Coronary Artery Disease V: Interprofessional Care
01:30Coronary Artery Disease III: Clinical Manifestations